Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL6283511

CCc1ccccn1.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
FDPS P14324 1/20 0.41
ALDH1A1 P00352 4/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
NR1H2 P55055 1/20 0.41
NR1H3 Q13133 1/20 0.41
CYP1A2 P05177 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TSHR P16473 1/20 0.41
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL9555532 1.00 LMNA (0.50) LMNATDP1FDPSALDH1A1NPC1
Sulfuric Acid SCHEMBL28279533 0.88 LMNA (0.57) LMNATDP1FDPSALDH1A1RAB9A
Sulfuric Acid SCHEMBL5169107 0.88 LMNA (0.57) LMNATDP1FDPSALDH1A1RAB9A
Sulfuric Acid SCHEMBL4948720 0.88 LMNA (0.57) LMNATDP1FDPSALDH1A1RAB9A
Sulfuric Acid SCHEMBL4948539 0.88 LMNA (0.57) LMNATDP1FDPSALDH1A1RAB9A
Trifluoromethanesulfonic Acid SCHEMBL26104061 0.87 LMNA (0.55) LMNATDP1ALDH1A1NPC1RAB9A
SCHEMBL4952632 0.86 LMNA (0.65) LMNATDP1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL27650840 0.86 LMNA (0.65) LMNATDP1ALDH1A1RAB9ASMN1; SMN2
Trifluoromethanesulfonic Acid SCHEMBL26103744 0.84 LMNA (0.52) LMNATDP1ALDH1A1NPC1RAB9A
Trifluoromethanesulfonic Acid SCHEMBL27938560 0.83 LMNA (0.51) LMNATDP1ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106731504-B A kind of H2S SCAVENGER and its application in the desulfurization of oil field 河北科技大学 2019-07-26 CN disclosed
US-6974870-B2 Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses BOEHRINGER INGELHEIM PHAMACEUTICALS, INC. (US) 2005-12-13 US disclosed
US-20040180922-A1 Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2004-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040180922-A1 Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses NFKBIA, IKBKB, CHUK LMNA 3819/4885TDP1 1133/4885FDPS 1292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.